Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.

Ning, Yan; Gerger, Armin; Zhang, Wu; Hanna, Diana L; Yang, Dongyun; Winder, Thomas; Wakatsuki, Takeru; Labonte, Melissa J; Stintzing, Sebastian; Volz, Nico; Sunakawa, Yu; Stremitzer, Stefan; El-Khoueiry, Rita; Lenz, Heinz-Josef

Ning, Yan; Gerger, Armin; Zhang, Wu; Hanna, Diana L; Yang, Dongyun; Winder, Thomas; Wakatsuki, Takeru; Labonte, Melissa J; Stintzing, Sebastian; Volz, Nico; Sunakawa, Yu; Stremitzer, Stefan; El-Khoueiry, Rita; Lenz, Heinz-Josef.

Affiliation

Ning Y; Corresponding Author: Heinz-Josef Lenz, Norris Comprehensive Cancer Center, Keck School of Medicine, 1441 Eastlake Avenue, Suite 3456, University of Southern California, Los Angeles, CA 90089. lenz@usc.edu.

Mol Cancer Ther ; 13(2): 528-39, 2014 Feb.

Article in En | MEDLINE | ID: mdl-24170770

Subject(s)

Colonic Neoplasms/drug therapy; Colonic Neoplasms/genetics; Membrane Glycoproteins/genetics; Microfilament Proteins/genetics; Polymorphism, Single Nucleotide; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Chemotherapy, Adjuvant; Colonic Neoplasms/pathology; Disease-Free Survival; Female; Fluorouracil/administration & dosage; Gene Frequency; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Sex Factors; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Membrane Glycoproteins / Colonic Neoplasms / Polymorphism, Single Nucleotide / Microfilament Proteins Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Mol Cancer Ther Year: 2014 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google